115 related articles for article (PubMed ID: 3232274)
1. Influence of interferon alfa-2c on the kinetics of spontaneous cell-mediated cytotoxicity in urothelial carcinoma in vivo and in vitro.
Grups JW; Stock T; Frohmüller HG
Urol Res; 1988; 16(6):399-402. PubMed ID: 3232274
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder.
Carballido JA; Moltó LM; Manzano L; Olivier C; Salmerón OJ; Alvarez de Mon M
Cancer; 1993 Sep; 72(5):1743-8. PubMed ID: 8348503
[TBL] [Abstract][Full Text] [Related]
3. Interferon beta enhances the natural killer activity of patients with bladder carcinoma.
Moltó L; Carballido J; Manzano L; Olivier C; Lapeña P; Alvarez-Mon M
Cancer Immunol Immunother; 1994 Jun; 38(6):406-10. PubMed ID: 8205562
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction of natural killer cells in patients with transitional cell carcinoma.
Lin CT; Yu MT; Li C; Ho YC; Shen CH; Liu DW; Chang DC; Wu SF
Cancer Lett; 2010 May; 291(1):39-45. PubMed ID: 19931980
[TBL] [Abstract][Full Text] [Related]
5. Keyhole limpet hemocyanine can enhance the natural killer activity of patients with transitional cell carcinoma of the bladder.
Moltó LM; Carballido J; Jurincic C; Lapeña P; Manzano L; Salmerón I; Klippel KF; Alvarez-Mon M
Eur Urol; 1991; 19(1):74-8. PubMed ID: 2007423
[TBL] [Abstract][Full Text] [Related]
6. Use of intracavitary interferon-alpha-2b in the prophylactic treatment of patients with superficial bladder cancer.
Moltó L; Alvarez-Mon M; Carballido J; Olivier C; Gimeno F; Manzano L
Cancer; 1995 Jun; 75(11):2720-6. PubMed ID: 7743476
[TBL] [Abstract][Full Text] [Related]
7. Thymostimulin enhances the natural cytotoxic activity of patients with transitional cell carcinoma of the bladder.
Moltó LM; Carballido JA; Manzano L; Olivier C; Lapuerta M; Alvarez-Mon M
Int J Immunopharmacol; 1993 Apr; 15(3):335-41. PubMed ID: 8505146
[TBL] [Abstract][Full Text] [Related]
8. Cellular cytotoxicity of human natural killer cells and lymphokine-activated killer cells against bladder carcinoma cell lines.
Wang MH; Flad HD; Böhle A; Chen YQ; Ulmer AJ
Immunol Lett; 1991 Mar; 27(3):191-7. PubMed ID: 2060970
[TBL] [Abstract][Full Text] [Related]
9. Natural killer (NK) cell assay within bladder mucosa of patients bearing transitional cell carcinoma (TCC) after interferon (IFN) therapy: an immunohistochemical and ultrastructural study.
Natsis K; Toliou T; Stravoravdi P; Kirtsis P; Grekou A; Barich A; Konstantinidis E; Gigis P
Int J Clin Pharmacol Res; 1997; 17(1):31-6. PubMed ID: 9403351
[TBL] [Abstract][Full Text] [Related]
10. Enhancement by X-ray irradiation of target cell susceptibility to natural killer cells.
Mizutani Y; Uchida A; Fujimoto T; Ikenaga M; Yoshida O
Immunol Lett; 1989 Sep; 22(3):247-51. PubMed ID: 2509333
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder.
Carballido J; Alvarez-Mon M; Solovera OJ; Menéndez-Ondina L; Durántez A
J Urol; 1990 Jan; 143(1):29-33. PubMed ID: 2294256
[TBL] [Abstract][Full Text] [Related]
12. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
13. Transitional cell carcinoma: lymphocyte-mediated cytotoxicity.
Troye M; Pape GR
Natl Cancer Inst Monogr; 1978 Dec; (49):85-7. PubMed ID: 311895
[TBL] [Abstract][Full Text] [Related]
14. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
Bkhatta AD; Makhlin NV
Urol Nefrol (Mosk); 1984; (2):67-70. PubMed ID: 6372193
[No Abstract] [Full Text] [Related]
15. An investigation of factors influencing the in vitro induction of LAK activity against a variety of human bladder cancer cell lines.
Jackson AM; Hawkyard SJ; Prescott S; Ritchie AW; James K; Chisholm GD
J Urol; 1992 Jan; 147(1):207-11. PubMed ID: 1729534
[TBL] [Abstract][Full Text] [Related]
16. In vivo effects of chloroquine treatment on spontaneous and interferon-induced natural killer activities in rheumatoid arthritis patients.
Ausiello CM; Barbieri P; Spagnoli GC; Ciompi ML; Casciani CU
Clin Exp Rheumatol; 1986; 4(3):255-9. PubMed ID: 3769242
[TBL] [Abstract][Full Text] [Related]
17. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
Uchida A; Yanagawa E; Kokoschka EM; Micksche M; Koren HS
Br J Cancer; 1984 Oct; 50(4):483-92. PubMed ID: 6237664
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effects of interferons against human bladder carcinoma cell lines in vitro.
Grups JW; Frohmüller HG
Urol Int; 1988; 43(5):265-8. PubMed ID: 2462294
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory effect of interferon-alpha 2b on natural killer cells and T lymphocytes from patients with transitional cell carcinoma of the bladder.
Alvarez-Mon M; Moltó LM; Manzano L; Olivier C; Carballido JA
Anticancer Drugs; 1992 May; 3 Suppl 1():5-8. PubMed ID: 1611117
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell activity in patients with urologic cancer.
Ma CP; Yu DS; Yeh MY; Chang SY; Han SH
Eur Urol; 1987; 13(6):397-400. PubMed ID: 3428323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
